Patents by Inventor Hira Lal GOEL

Hira Lal GOEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920135
    Abstract: Methods and compositions for treating cancer, e.g., prostate cancer, using a combination of P-Rex1 or Rac1 inhibitors and VEGF/VEGFR-targeted therapy.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: March 5, 2024
    Assignee: University of Massachusetts
    Inventors: Hira Lal Goel, Arthur M. Mercurio
  • Publication number: 20210163954
    Abstract: Methods and compositions for treating cancer, e.g., prostate cancer, using a combination of P-Rex1 or Rac1 inhibitors and VEGF/VEGFR-targeted therapy.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 3, 2021
    Inventors: Hira Lal Goel, Arthur M. Mercurio
  • Patent number: 10947537
    Abstract: Methods and compositions for treating cancer, e.g., prostate cancer, using a combination of P-Rex1 or Rac1 inhibitors and VEGF/VEGFR-targeted therapy.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: March 16, 2021
    Assignee: University of Massachusetts
    Inventors: Hira Lal Goel, Arthur M. Mercurio
  • Publication number: 20190040396
    Abstract: Methods and compositions for treating cancer, e.g., prostate cancer, using a combination of P-Rex1 or Rac1 inhibitors and VEGF/VEGFR-targeted therapy.
    Type: Application
    Filed: February 16, 2017
    Publication date: February 7, 2019
    Inventors: Hira Lal GOEL, Arthur M. MERCURIO